Eli Lilly and Co. shared in a statement on Tuesday that, according to the latest indirect treatment comparison, "Zepbound (tirzepatide) 10 mg and 15 mg ... delivered greater weight loss than Wegovy HD...
Eli Lilly reported that specific doses of her slimming cane, the Zepbound, provided a weight reduction higher than that obtained with the high-dose version of the competitor Wegovy, developed by rival Novo, according to a recent analysis. Exclusive material for subscribers. To have full access, access the link of the material and register.